CAS 245329-02-6

L-Tyrosinamide, L-phenylalanyl-L-seryl-L-leucyl-L-leucyl-L-arginyl-

Description:

L-Tyrosinamide, L-phenylalanyl-L-seryl-L-leucyl-L-leucyl-L-arginyl- is a peptide compound characterized by its specific sequence of amino acids, which includes tyrosine, phenylalanine, serine, leucine, and arginine. This compound is likely to exhibit properties typical of peptides, such as solubility in water and the ability to form hydrogen bonds due to the presence of polar side chains. The presence of aromatic amino acids like tyrosine and phenylalanine may contribute to its hydrophobic characteristics, while the basic side chain of arginine can impart positive charge under physiological conditions. Peptides like this one often play roles in biological processes, including signaling and enzyme activity. Additionally, the specific arrangement of amino acids can influence the compound's three-dimensional structure, stability, and interactions with other biomolecules. As a synthetic or naturally occurring peptide, it may have potential applications in pharmaceuticals or biochemistry, although further research would be necessary to elucidate its specific functions and therapeutic potential.

Formula: C₃₉H₆₀N₁₀O₈

InChI: InChI=1S/C39H60N10O8/c1-22(2)17-30(36(55)45-28(11-8-16-44-39(42)43)35(54)46-29(33(41)52)20-25-12-14-26(51)15-13-25)47-37(56)31(18-23(3)4)48-38(57)32(21-50)49-34(53)27(40)19-24-9-6-5-7-10-24/h5-7,9-10,12-15,22-23,27-32,50-51H,8,11,16-21,40H2,1-4H3,(H2,41,52)(H,45,55)(H,46,54)(H,47,56)(H,48,57)(H,49,53)(H4,42,43,44)/t27-,28-,29-,30-,31-,32-/m0/s1

InChI key: KMSCNWHRNILNRJ-JNRWAQIZSA-N

SMILES: CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=CC=C2)N

(Phe¹,Ser²,Tyr⁶)-PAR-1 (1-6) amide (human)

CAS: 245329-02-6

PAR-2 antagonist. FSLLRY-amide inhibited activation of PAR-2 by trypsin in PAR-2 receptor expressing KNRK cells. Half-maximal inhibition of calcium signaling was observed at about 50 µM. In contrast, the activation of PAR-2 by SLIGRL-amide was not inhibited by FSLLRY-amide.

Formula: C₃₉H₆₀N₁₀O₈

Purity: 99.3%

Molecular weight: 796.97

Ref: 01-4041474

L-Phenylalanyl-L-seryl-L-leucyl-L-leucyl-L-arginyl-L-tyrosinamide

CAS: 245329-02-6

L-Phenylalanyl-L-seryl-L-leucyl-L-leucyl-L-arginyl-L-tyrosinamide

Formula: C₃₉H₆₀N₁₀O₈

Purity: ≥98%

Molecular weight: 796.96

Ref: 54-OR1115347

FSLLRY-NH2

CAS: 245329-02-6

PAR2 antagonist; counters taxol effects, PKC in mice; inhibits ERK, collagen in fibroblasts; lessens dermatophyte itch in mice.

Formula: C₃₉H₆₀N₁₀O₈

Purity: 98%

Color and Shape: Solid

Molecular weight: 796.9559

Ref: TM-TP1904

L-Phenylalanyl-L-seryl-L-leucyl-L-leucyl-L-arginyl-L-tyrosinamide

CAS: 245329-02-6

Formula: C₃₉H₆₀N₁₀O₈

Purity: 98%

Color and Shape: Solid

Molecular weight: 796.9559

Ref: IN-DA00BDRR

H-Phe-Ser-Leu-Leu-Arg-Tyr-NH2

CAS: 245329-02-6

This is a synthetic peptide that was originally isolated from human colon tissue. It has been shown to sensitize dorsal root ganglia neurons in vitro, producing a response to the neurotransmitter acetylcholine. This peptide also induces apoptosis in neuronal cells and increases the permeability of blood vessels in tissues by activating vasoactive intestinal peptide (VIP) receptors. The effects of this peptide were studied in humans with bowel disease or inflammatory bowel disease. It was found that it may be effective for treating these diseases as well as necrosis factor-mediated inflammation. This peptide is also known to activate IL-10, which is an anti-inflammatory cytokine.

Formula: C₃₉H₆₀N₁₀O₈

Purity: Min. 95%

Molecular weight: 796.98 g/mol

Ref: 3D-PAR-3888-PI

(Phe1,Ser2,Tyr6)-PAR-1 (1-6) amide (human) trifluoroacetate salt

CAS: 245329-02-6

Please enquire for more information about (Phe1,Ser2,Tyr6)-PAR-1 (1-6) amide (human) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formula: C₃₉H₆₀N₁₀O₈

Purity: Min. 95%

Molecular weight: 796.96 g/mol

Ref: 3D-FP109784